A Prospective, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy of Bacillus Coagulans Unique IS2 on Improving Bowel Movement Characteristics, Gastrointestinal-related Symptoms and Quality of Life in Healthy Adult Participants

NACompletedINTERVENTIONAL

Enrollment

143

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

December 20, 2023

Study Completion Date

December 20, 2023

Conditions

Stool Frequency

Interventions

OTHER

Capsule

1 cap daily at same time of the day with or without food for 4 weeks

Trial Locations (1)

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.: Nutrasource Clinical Trial Site, Guelph

All Listed Sponsors

lead

PepsiCo Global R&D

INDUSTRY